Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000074 |
Acenocoumarol |
APOE gene polymorphism affects the susceptibility to Acenocoumarol | affects response to substance | 15861030
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of APOE protein | affects expression | 16099942
|
D000082 |
Acetaminophen |
Acetaminophen results in decreased expression of APOE protein | decreases expression | 16687475
|
D000109 |
Acetylcholine |
APOE protein affects the susceptibility to Acetylcholine | affects response to substance | 17899169
|
D000171 |
Acrolein |
Acrolein affects the folding of APOE protein | affects folding | 17580963
|
D000171 |
Acrolein |
Acrolein results in decreased activity of APOE protein | decreases activity | 17580963
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of APOE protein | affects expression | 20106945
|
C096920 |
AGN 193109 |
AGN 193109 inhibits the reaction [Tretinoin results in increased expression of APOE mRNA] | decreases reaction|increases expression | 16505366
|
D013196 |
Dihydrotestosterone |
APOE gene polymorphism affects the reaction [Dihydrotestosterone affects the phosphorylation of MAPK10 protein] | affects phosphorylation|affects reaction | 17395708
|
D013196 |
Dihydrotestosterone |
APOE gene polymorphism affects the reaction [Dihydrotestosterone affects the phosphorylation of MAPK9 protein] | affects phosphorylation|affects reaction | 17395708
|
D013196 |
Dihydrotestosterone |
APOE gene polymorphism affects the susceptibility to Dihydrotestosterone | affects response to substance | 17395708
|
C061621 |
alpha-naphthyl isocyanate |
alpha-naphthyl isocyanate affects the expression of APOE protein | affects expression | 16099942
|
D000638 |
Amiodarone |
Amiodarone results in decreased expression of APOE mRNA | decreases expression | 17991464
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of APOE mRNA | affects expression | 16483693
|
D001151 |
Arsenic |
APOE polymorphism results in increased susceptibility to Arsenic | increases response to substance | 18022660
|
C065179 |
atorvastatin |
[Bezafibrate co-treated with Enalapril co-treated with Dipyridamole co-treated with atorvastatin co-treated with valsartan] results in decreased expression of APOE protein | affects cotreatment|decreases expression | 19603250
|
D001629 |
Bezafibrate |
[Bezafibrate co-treated with Enalapril co-treated with Dipyridamole co-treated with atorvastatin co-treated with valsartan] results in decreased expression of APOE protein | affects cotreatment|decreases expression | 19603250
|
C053342 |
brevetoxin |
brevetoxin analog results in decreased expression of APOE mRNA | decreases expression | 14529743
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of APOE mRNA | increases expression | 15336504
|
D002118 |
Calcium |
APOE protein affects the abundance of Calcium | affects abundance | 17899169
|
D002118 |
Calcium |
Calcium affects the expression of APOE mRNA | affects expression | 15913539
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of APOE protein | increases expression | 16845489
|
D002784 |
Cholesterol |
APOE protein affects the susceptibility to Cholesterol | affects response to substance | 16179587
|
D002791 |
Cholesterol, Dietary |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of APOE mRNA | affects cotreatment|decreases expression | 19509184
|
D008076 |
Cholesterol, HDL |
APOE gene polymorphism affects the abundance of Cholesterol, HDL | affects abundance | 16030523
|
D003520 |
Cyclophosphamide |
Cyclophosphamide results in decreased expression of APOE mRNA | decreases expression | 15331540
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of APOE mRNA | decreases expression | 20106945
|
C017160 |
cypermethrin |
cypermethrin results in decreased expression of APOE mRNA | decreases expression | 9650644 11428908
|
D004041 |
Dietary Fats |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of APOE mRNA | affects cotreatment|decreases expression | 19509184
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of APOE mRNA | decreases expression | 18042831
|
D004052 |
Diethylnitrosamine |
[Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of APOE protein | affects cotreatment|increases expression | 20935162
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of APOE mRNA | increases expression | 15766595
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in decreased expression of APOE mRNA | decreases expression | 15171707
|
D004176 |
Dipyridamole |
[Bezafibrate co-treated with Enalapril co-treated with Dipyridamole co-treated with atorvastatin co-treated with valsartan] results in decreased expression of APOE protein | affects cotreatment|decreases expression | 19603250
|
D004656 |
Enalapril |
[Bezafibrate co-treated with Enalapril co-treated with Dipyridamole co-treated with atorvastatin co-treated with valsartan] results in decreased expression of APOE protein | affects cotreatment|decreases expression | 19603250
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of APOE mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of APOE mRNA | decreases expression | 14976129 16174780 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of APOE mRNA | affects cotreatment|decreases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of APOE mRNA | decreases expression | 17351261 17557909
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of APOE mRNA | increases expression | 16174780
|
D015025 |
Zearalenone |
Zearalenone results in decreased expression of APOE mRNA | decreases expression | 19371625
|
D005632 |
Fructose |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of APOE mRNA | affects cotreatment|decreases expression | 19509184
|
C100093 |
gentamicin C |
APOE protein inhibits the reaction [gentamicin C results in decreased expression of and results in decreased activity of SLC5A1 protein] | decreases activity|decreases expression|decreases reaction | 15777622
|
C100093 |
gentamicin C |
APOE protein inhibits the reaction [gentamicin C results in decreased expression of SLC5A1 mRNA] | decreases expression|decreases reaction | 15777622
|
C100093 |
gentamicin C |
APOE protein results in decreased uptake of gentamicin C | decreases uptake | 15777622
|
C473027 |
GW 3965 |
GW 3965 results in increased expression of APOE mRNA | increases expression | 17449538
|
C029424 |
hydrazine |
hydrazine results in decreased expression of APOE mRNA | decreases expression | 15370871
|
C029424 |
hydrazine |
hydrazine results in decreased expression of APOE protein | decreases expression | 15370871
|
D000960 |
Hypolipidemic Agents |
Hypolipidemic Agents results in decreased expression of APOE protein | decreases expression | 19603250
|
D007501 |
Iron |
APOE gene polymorphism results in increased susceptibility to Iron | increases response to substance | 15993987
|
D007657 |
Ketone Bodies |
Ketone Bodies results in increased expression of APOE mRNA | increases expression | 16807920
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of APOE mRNA | decreases expression | 16847310
|
C029938 |
nickel sulfate |
nickel sulfate results in decreased expression of APOE mRNA | decreases expression | 16780908
|
C029938 |
nickel sulfate |
nickel sulfate results in increased expression of APOE mRNA | increases expression | 16780908
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in decreased expression of APOE mRNA | decreases expression | 17616710
|
D010126 |
Ozone |
Ozone results in decreased expression of APOE mRNA | decreases expression | 12763052
|
C041786 |
palm oil |
palm oil results in decreased expression of APOE mRNA | decreases expression | 18042831
|
C084656 |
paricalcitol |
[Phosphorus co-treated with paricalcitol] results in decreased expression of APOE mRNA | affects cotreatment|decreases expression | 17715259
|
D010634 |
Phenobarbital |
Phenobarbital affects the expression of APOE protein | affects expression | 16099942
|
D010634 |
Phenobarbital |
[Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of APOE protein | affects cotreatment|increases expression | 20935162
|
D010656 |
Phenylephrine |
APOE protein affects the susceptibility to Phenylephrine | affects response to substance | 17899169
|
D010672 |
Phenytoin |
Phenytoin results in increased expression of APOE mRNA | increases expression | 15136057
|
D010758 |
Phosphorus |
[Phosphorus co-treated with paricalcitol] results in decreased expression of APOE mRNA | affects cotreatment|decreases expression | 17715259
|
D010840 |
Phytosterols |
APOE gene mutant form affects the reaction [Phytosterols results in increased expression of CYP51 mRNA] | affects reaction|increases expression | 18155511
|
D010840 |
Phytosterols |
APOE gene mutant form affects the reaction [Phytosterols results in increased expression of CYP7B1 mRNA] | affects reaction|increases expression | 18155511
|
D010840 |
Phytosterols |
APOE gene mutant form affects the reaction [Phytosterols results in increased expression of FADS1 mRNA] | affects reaction|increases expression | 18155511
|
D010840 |
Phytosterols |
APOE gene mutant form affects the reaction [Phytosterols results in increased expression of FADS2 mRNA] | affects reaction|increases expression | 18155511
|
D010840 |
Phytosterols |
APOE gene mutant form affects the reaction [Phytosterols results in increased expression of HMGCR mRNA] | affects reaction|increases expression | 18155511
|
D010840 |
Phytosterols |
APOE gene mutant form affects the reaction [Phytosterols results in increased expression of HMGCS1 mRNA] | affects reaction|increases expression | 18155511
|
D010840 |
Phytosterols |
APOE gene mutant form affects the reaction [Phytosterols results in increased expression of HSD17B7 mRNA] | affects reaction|increases expression | 18155511
|
D010840 |
Phytosterols |
APOE gene mutant form affects the reaction [Phytosterols results in increased expression of LPIN1 mRNA] | affects reaction|increases expression | 18155511
|
D010840 |
Phytosterols |
APOE gene mutant form affects the reaction [Phytosterols results in increased expression of PPARGC1B mRNA] | affects reaction|increases expression | 18155511
|
D010840 |
Phytosterols |
APOE gene mutant form affects the reaction [Phytosterols results in increased expression of SQLE mRNA] | affects reaction|increases expression | 18155511
|
C006253 |
pirinixic acid |
pirinixic acid affects the expression of APOE protein | affects expression | 16099942
|
C025299 |
polyphenols |
polyphenols results in decreased expression of APOE protein | decreases expression | 16046716
|
D011794 |
Quercetin |
Quercetin results in increased expression of APOE mRNA | increases expression | 16455785
|
C059514 |
resveratrol |
resveratrol results in increased expression of APOE mRNA | increases expression | 19371625
|
C009166 |
retinol acetate |
retinol acetate results in increased expression of APOE mRNA | increases expression | 16772331
|
D012643 |
Selenium |
Selenium results in increased expression of APOE mRNA | increases expression | 19244175
|
D012643 |
Selenium |
Selenium affects the expression of APOE protein | affects expression | 17996733
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of APOE mRNA | decreases expression | 19822182
|
D013311 |
Streptozocin |
Streptozocin results in increased expression of APOE mRNA | increases expression | 16684804
|
D013311 |
Streptozocin |
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of APOE mRNA] | decreases reaction|increases expression | 16684804
|
D013629 |
Tamoxifen |
APOE gene polymorphism affects the susceptibility to Tamoxifen | affects response to substance | 19103187
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of APOE mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of APOE mRNA | increases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
APOE protein affects the susceptibility to Tetrachlorodibenzodioxin | affects response to substance | 12213967
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of APOE mRNA | affects cotreatment|decreases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of APOE mRNA | decreases expression | 15703262
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of APOE mRNA | increases expression | 16267337
|
C423915 |
TO-901317 |
TO-901317 results in increased expression of APOE mRNA | increases expression | 17449538
|
C423915 |
TO-901317 |
TO-901317 results in increased expression of APOE mRNA | increases expression | 19665519
|
C024746 |
tobacco tar |
tobacco tar results in decreased expression of APOE mRNA | decreases expression | 19559774
|
C066340 |
tolcapone |
tolcapone binds to APOE protein | affects binding | 19783845
|
D014212 |
Tretinoin |
AGN 193109 inhibits the reaction [Tretinoin results in increased expression of APOE mRNA] | decreases reaction|increases expression | 16505366
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of APOE mRNA | increases expression | 16505366
|
D014331 |
Tropicamide |
APOE gene polymorphism results in increased susceptibility to Tropicamide | increases response to substance | 8724673 9137131
|
C081489 |
valsartan |
[Bezafibrate co-treated with Enalapril co-treated with Dipyridamole co-treated with atorvastatin co-treated with valsartan] results in decreased expression of APOE protein | affects cotreatment|decreases expression | 19603250
|
C081489 |
valsartan |
valsartan inhibits the reaction [AGT protein results in decreased expression of APOE protein] | decreases expression|decreases reaction | 17785354
|
C034028 |
vanadyl sulfate |
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of APOE mRNA] | decreases reaction|increases expression | 16684804
|
D014812 |
Vitamin K |
APOE protein affects the abundance of Vitamin K | affects abundance | 15952022
|
D014812 |
Vitamin K |
APOE protein affects the uptake of Vitamin K | affects uptake | 16847429
|
D014859 |
Warfarin |
APOE gene polymorphism affects the susceptibility to Warfarin | affects response to substance | 17325732 16847429 17048007
|
D014859 |
Warfarin |
APOE protein affects the susceptibility to Warfarin | affects response to substance | 15952022
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
3.86 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
10.49 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenytoin |
10.49 | 10563481 9677735 6195326 8986270 3425630 9118846 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
10.49 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
2.89 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.26 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.26 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Acrolein |
16.75 | 21297076 20525806 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
16.75 | 18653653 11850527 |
MESH:D055371 |
Acute Lung Injury |
|
nickel sulfate |
16.75 | 16100012 19131640 12718980 11954676 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
16.75 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.62 | 14692618 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
5.45 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
resveratrol |
5.45 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
19.38 | 19061943 16434500 17620307 17162532 19052882 18056438 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
19.38 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
19.38 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
19.38 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.01 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
11.52 | 17306315 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
11.52 | 17306315 16712894 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
cypermethrin |
4.27 | 16487989 |
MESH:D017109 |
Akathisia, Drug-Induced |
|
tolcapone |
5.61 | 11080934 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.07 | 15955085 |
MESH:D019896 |
alpha 1-Antitrypsin Deficiency |
|
Iron |
4.98 | 16640825 |
MESH:D000544 |
Alzheimer Disease |
marker/mechanism |
|
| 19734902 |
MESH:D000544 |
Alzheimer Disease |
|
Acrolein |
13.14 | 14715435 17570602 15207723 |
MESH:D000544 |
Alzheimer Disease |
|
Cholesterol, Dietary |
13.14 | 20157255 |
MESH:D000544 |
Alzheimer Disease |
|
Iron |
13.14 | 16640825 16563566 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
13.14 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
13.14 | 16162502 16183991 |
MESH:D000544 |
Alzheimer Disease |
|
tolcapone |
13.14 | 20150427 |
MESH:C536595 |
Alzheimer disease type 2 |
marker/mechanism |
|
| |
MESH:D000686 |
Amyloidosis |
marker/mechanism |
|
| 15993987 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
3.84 | 15469931 |
MESH:D000740 |
Anemia |
|
Iron |
6.97 | 16434484 16566752 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
6.97 | 11748828 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
3.63 | 17084956 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Iron |
4.06 | 17375513 16569441 17163184 17162259 17147795 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Iron |
4.20 | 16910769 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.16 | 10982225 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
11.66 | 18057881 20041841 18218290 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Iron |
11.66 | 16604332 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
11.66 | 17460149 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.64 | 16835338 16251483 18414634 12569548 |
MESH:D001161 |
Arteriosclerosis |
|
Acrolein |
25.06 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Cholesterol, Dietary |
25.06 | 15552841 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
25.06 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
25.06 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
25.06 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
9.66 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
9.66 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
9.66 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
3.96 | 15570426 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
3.96 | 16292516 |
MESH:D001249 |
Asthma |
|
Ozone |
4.08 | 17854713 16373670 |
MESH:D001249 |
Asthma |
|
Tretinoin |
4.08 | 16456186 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Iron |
10.88 | 15336622 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
10.88 | 15336622 |
MESH:D050197 |
Atherosclerosis |
marker/mechanism |
|
| 9169506 |
MESH:D050197 |
Atherosclerosis |
|
Acrolein |
20.06 | 16126721 16037261 17363696 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
20.06 | 12928151 19371607 |
MESH:D050197 |
Atherosclerosis |
|
Cholesterol |
20.06 | 16632123 |
MESH:D050197 |
Atherosclerosis |
|
Iron |
20.06 | 16640825 16632123 |
MESH:D050197 |
Atherosclerosis |
|
Phenytoin |
20.06 | 15136057 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
20.06 | 16873680 17967414 |
MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
3.38 | 18651412 19698954 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.16 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Iron |
2.16 | 17352947 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
3.75 | 19761891 |
MESH:D001424 |
Bacterial Infections |
|
Iron |
4.52 | 16640825 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.76 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
17.01 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
17.01 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
17.01 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
17.01 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.11 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.30 | 15746008 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
3.88 | 15306635 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
3.62 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
4.84 | 18234424 15093573 17388661 15136595 11325840 16978400 17020986 12006526 18323546 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
4.84 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
4.84 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
4.84 | 17129689 15324884 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
4.84 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
4.84 | 17651959 17534123 16393696 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
4.84 | 17242785 15565566 16818667 17049068 19155303 15668708 20065188 19011961 20135344 19221464 18821012 19142967 18629630 20544844 19066611 18815881 18351453 16202921 19289846 19189212 18425577 19115204 11161223 19084267 18997820 16873071 18855134 17440819 19103187 17893378 19200415 19189210 19244106 19410462 21152245 21138602 17261762 19487384 20390343 20005174 18984771 19059307 20859285 19288272 16273361 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.84 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
4.84 | 16443354 16873071 16166294 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.14 | 18417511 19059883 15516495 16777450 18315731 14754758 17626835 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
3.92 | 16813970 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.07 | 16183385 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
4.86 | 16962696 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.13 | 18705752 16050911 3786805 15700767 10355542 15673190 16097048 16227642 16124888 16192424 16011737 15721981 |
MESH:D002276 |
Carcinoid Tumor |
|
Streptozocin |
4.92 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.26 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.17 | 15504454 17687452 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
3.85 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.47 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
31.31 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
31.31 | 12907637 12619106 21507988 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
31.31 | 16507464 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
31.31 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
31.31 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
31.31 | 20727157 20524982 18393292 17428255 19539802 16779866 16328049 16288022 16502159 11831363 19208518 19171122 3084413 19822196 17055752 17978847 19701751 17173139 17761372 17138121 18210153 20007298 16935385 20935162 20214788 18506893 19052882 21159647 16569478 20512989 18494052 19394651 10672840 19107877 20514400 18691550 18785209 18056438 20084675 3581430 16807293 16698587 16681979 19418558 19919837 17162532 18971187 19383236 20101231 10737359 18978308 18665156 19519916 16540662 16878318 16830150 20432363 19335982 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
31.31 | 16924424 15948411 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
31.31 | 20935162 1701930 6705139 17173139 20007298 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
31.31 | 19519916 12508355 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
31.31 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
31.31 | 17306315 15276417 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
31.31 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
31.31 | 1917145 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Vitamin K |
31.31 | 16328049 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
9.26 | 16152834 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
9.26 | 16675471 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.30 | 17234771 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
3.18 | 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
8.72 | 15504454 18922899 17687452 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
8.72 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
8.72 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
8.72 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
7.54 | 18640142 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
7.54 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
atorvastatin |
17.10 | 18360054 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
17.10 | 15728586 11754973 17124262 17287366 11179087 16170337 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
17.10 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
17.10 | 18670907 18850075 16120746 |
MESH:D006332 |
Cardiomegaly |
|
valsartan |
17.10 | 19597038 |
MESH:D009202 |
Cardiomyopathies |
|
Iron |
6.93 | 16640825 |
MESH:D009202 |
Cardiomyopathies |
|
valsartan |
6.93 | 16247790 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
5.21 | 15710769 19225199 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Iron |
5.21 | 16604332 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
9.55 | 15738583 19152805 17938729 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
9.55 | 15458977 |
MESH:D002318 |
Cardiovascular Diseases |
|
valsartan |
9.55 | 11230374 |
MESH:D002340 |
Carotid Artery Diseases |
marker/mechanism |
|
| 18022660 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
3.73 | 16973168 18022660 |
MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
4.41 | 18974383 |
MESH:D016893 |
Carotid Stenosis |
marker/mechanism |
|
| 17243563 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
5.78 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
5.78 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
12.07 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
12.07 | 7505956 17174075 2727394 21159647 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
12.07 | 19524636 20056578 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
tobacco tar |
12.07 | 19559774 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
9.49 | 4080065 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenytoin |
9.49 | 4080065 |
MESH:D016657 |
Cerebral Amyloid Angiopathy |
marker/mechanism |
|
| 11061249 |
MESH:D002543 |
Cerebral Hemorrhage |
|
Warfarin |
5.20 | 11061249 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
3.92 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
7.41 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
7.41 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
10.35 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
10.35 | 17110522 11677210 15861022 17333356 16105132 17681005 16919318 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
10.35 | 19176532 |
OMIM:601042 |
CHOREOATHETOSIS/SPASTICITY, EPISODIC |
|
Phenytoin |
5.20 | 11748493 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.47 | 16461808 |
MESH:D002971 |
Cleft Lip |
|
Phenytoin |
3.76 | 2227380 |
MESH:D002972 |
Cleft Palate |
|
Phenytoin |
7.97 | 6856622 3877104 2227380 10789828 6862529 1687470 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
7.97 | 12621046 15340226 15668235 16354765 8697196 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
7.97 | 9407595 |
MESH:D003092 |
Colitis |
|
resveratrol |
12.27 | 16474422 |
MESH:D003092 |
Colitis |
|
Selenium |
12.27 | 17936198 |
MESH:D003092 |
Colitis |
|
Tretinoin |
12.27 | 17035595 |
MESH:D003103 |
Coloboma |
|
Phenytoin |
4.54 | 9212184 |
MESH:D003110 |
Colonic Neoplasms |
|
Iron |
6.89 | 16640825 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
6.89 | 16293270 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
6.89 | 19440933 11134977 15741050 16640504 19056647 17191121 17148506 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
6.89 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Acrolein |
3.17 | 17597105 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
3.17 | 18095365 18852136 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
3.17 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Phenytoin |
7.48 | 10627286 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
7.48 | 14669216 17141729 |
MESH:D003324 |
Coronary Artery Disease |
|
atorvastatin |
5.92 | 16368305 |
MESH:D003324 |
Coronary Artery Disease |
|
valsartan |
5.92 | 17719468 |
MESH:D003327 |
Coronary Disease |
|
Fructose |
7.23 | 18504504 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
7.23 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
Warfarin |
5.04 | 12872399 |
MESH:D003371 |
Cough |
|
Enalapril |
5.54 | 11725383 |
OMIM:122700 |
COUMARIN RESISTANCE |
|
Warfarin |
5.20 | 20579077 20497562 |
MESH:D003384 |
Coxsackievirus Infections |
|
valsartan |
5.17 | 20392896 |
MESH:D006259 |
Craniocerebral Trauma |
marker/mechanism |
|
| |
MESH:D019465 |
Craniofacial Abnormalities |
|
Phenytoin |
3.31 | 8986270 9212184 19952982 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.31 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.31 | 9664655 10589399 14991402 17551590 9125849 16925845 8800419 9142499 9224671 9211117 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
3.92 | 16002989 12952375 |
MESH:D003556 |
Cystitis |
|
Acrolein |
9.81 | 12161096 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
9.81 | 10700343 12913760 17010015 17979934 18295254 18433785 16651033 15643279 18483878 18710439 12161096 12388444 10498854 16989017 18093676 16413132 18372110 16614059 11948286 15276878 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.71 | 19031437 |
MESH:D003866 |
Depressive Disorder |
|
tolcapone |
3.81 | 11224284 7768276 |
MESH:D003865 |
Depressive Disorder, Major |
|
tolcapone |
4.33 | 10440460 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
nickel sulfate |
3.07 | 11298694 16780908 16823706 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.07 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Iron |
7.92 | 16640825 16604332 |
MESH:D003920 |
Diabetes Mellitus |
|
Streptozocin |
7.92 | 16285004 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
30.33 | 11751995 10990075 15331540 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Fructose |
30.33 | 18603373 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
30.33 | 19496084 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
30.33 | 16873680 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Streptozocin |
30.33 | 12093613 15862027 12644472 17874149 17442507 12083368 6379147 12446591 15298345 19586609 19298542 19496084 11055810 18715473 8740154 16286809 7637645 18603373 19960420 11260395 1374869 2177838 16684804 15831366 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
valsartan |
30.33 | 11508273 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
vanadyl sulfate |
30.33 | 16684804 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
10.66 | 18772604 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Iron |
10.66 | 16506275 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Streptozocin |
10.66 | 18603373 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Warfarin |
10.66 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
11.27 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Fructose |
11.27 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Iron |
11.27 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Streptozocin |
11.27 | 19586609 19647726 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
11.27 | 17107852 |
MESH:D058065 |
Diabetic Cardiomyopathies |
|
Streptozocin |
5.05 | 16025228 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
22.08 | 16286809 |
MESH:D003928 |
Diabetic Nephropathies |
|
Streptozocin |
22.08 | 19682444 19960420 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
22.08 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
valsartan |
22.08 | 11427623 18630688 |
MESH:D003928 |
Diabetic Nephropathies |
|
Warfarin |
22.08 | 12644472 |
MESH:D003930 |
Diabetic Retinopathy |
|
Streptozocin |
4.78 | 17662242 |
OMIM:607208 |
DRAVET SYNDROME |
|
Phenytoin |
4.73 | 11748493 |
MESH:D003875 |
Drug Eruptions |
|
Phenytoin |
10.80 | 15024534 |
MESH:D003875 |
Drug Eruptions |
|
Warfarin |
10.80 | 14723717 |
MESH:D056486 |
Drug-Induced Liver Injury |
marker/mechanism |
|
| 16099942 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
17.63 | 17522070 14550746 16227642 17562736 11834606 10663392 14986274 19370779 15619225 19164858 11421492 12594235 15968718 11529661 12958197 16393943 19420014 12392966 10774834 19923254 19085960 2444490 16109766 12540782 14725611 12153990 12705907 16485898 19416960 11287661 16177239 11743745 18071297 18713872 16781746 16081117 19739265 17906064 11739529 11461765 10915739 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
17.63 | 18218290 15265979 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
17.63 | 7120509 10092053 3732212 15027814 6884620 21278145 7179309 10915739 15998439 19336974 3786805 16177239 6623471 19085960 16227642 2869522 7440962 9327722 17522070 4309450 11566570 15968718 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
17.63 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
17.63 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
17.63 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
17.63 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
tolcapone |
17.63 | 16604736 19783845 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.41 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.25 | 11462148 |
MESH:D004409 |
Dyskinesia, Drug-Induced |
|
tolcapone |
4.72 | 11455177 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
2.95 | 18367378 |
MESH:D004417 |
Dyspnea |
|
cypermethrin |
4.71 | 16487989 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.38 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
8.00 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
8.00 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
8.00 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
9.67 | 16714409 18230668 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
9.67 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
16.77 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Phenytoin |
16.77 | 17654737 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
16.77 | 17872969 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
16.77 | 19031437 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
4.02 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
9.76 | 15700306 16804899 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
9.76 | 20544844 19155303 17893378 16202921 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
9.76 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.44 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
3.73 | 15328337 15821434 17637181 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.19 | 17923197 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
3.57 | 11006010 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Phenytoin |
4.56 | 20235791 |
MESH:D004820 |
Epidermolysis Bullosa |
|
Phenytoin |
5.55 | 6251365 1399206 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.45 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
8.08 | 3922381 11558140 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenytoin |
8.08 | 17116037 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
5.73 | 20417680 |
MESH:D004827 |
Epilepsy |
|
Phenytoin |
5.73 | 11434505 20417680 821787 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
2.97 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
9.49 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenytoin |
9.49 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
8.63 | 3659116 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenytoin |
8.63 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.43 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
2.58 | 15878914 15623463 16510608 16704527 15547733 15150132 15264214 15547721 16805852 |
MESH:D054908 |
Extensively Drug-Resistant Tuberculosis |
|
tolcapone |
5.26 | 19578428 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.10 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.10 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Amiodarone |
43.27 | 14986274 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
43.27 | 61145 16239168 19224547 15959796 12795759 16045604 12631006 17595544 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
43.27 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
43.27 | 17967931 19004024 18296743 19551842 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
43.27 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
43.27 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Fructose |
43.27 | 18395287 18641190 19196556 |
MESH:D005234 |
Fatty Liver |
|
Iron |
43.27 | 16640825 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
43.27 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
43.27 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
6.73 | 16534752 16513791 16611131 16002989 15751030 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
6.73 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Phenytoin |
8.56 | 10627286 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
8.56 | 11858732 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.43 | 11852909 9205823 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
3.86 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.51 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
37.16 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
37.16 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
37.16 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Fructose |
37.16 | 18504504 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
37.16 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
37.16 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
37.16 | 17994277 |
MESH:D005355 |
Fibrosis |
|
valsartan |
37.16 | 16893502 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
4.87 | 6392382 |
MESH:D005621 |
Friedreich Ataxia |
|
Iron |
4.77 | 16640825 16604332 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
2.99 | 16983495 |
MESH:D006471 |
Gastrointestinal Hemorrhage |
|
Warfarin |
6.03 | 11794436 |
MESH:D005776 |
Gaucher Disease |
|
Warfarin |
5.32 | 12359135 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
10.58 | 16452187 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
10.58 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
10.68 | 8708960 |
MESH:D005885 |
Gingival Hyperplasia |
|
Phenytoin |
10.68 | 9029455 |
MESH:D019214 |
Gingival Overgrowth |
|
Phenytoin |
5.55 | 16390469 14659971 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
5.70 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
5.70 | 17312396 |
MESH:D005910 |
Glioma |
|
Quercetin |
2.75 | 17643826 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
4.84 | 11389073 |
MESH:D015432 |
Glomerulonephritis, Membranoproliferative |
|
valsartan |
4.90 | 16928621 |
MESH:D018149 |
Glucose Intolerance |
|
Fructose |
4.70 | 19165636 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.91 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.38 | 15172196 11014644 16376943 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
2.71 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.47 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.21 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
5.21 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
Streptozocin |
3.79 | 12093613 |
MESH:D006333 |
Heart Failure |
|
atorvastatin |
17.49 | 16360360 |
MESH:D006333 |
Heart Failure |
|
Enalapril |
17.49 | 10979640 12514674 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
17.49 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
17.49 | 17162251 |
MESH:D006333 |
Heart Failure |
|
valsartan |
17.49 | 19027736 |
MESH:D006406 |
Hematoma |
|
Warfarin |
6.03 | 17493413 |
MESH:D006432 |
Hemochromatosis |
|
Iron |
3.98 | 17053826 16640825 16604332 16574947 17255318 17236123 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.75 | 15720958 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
3.79 | 16366002 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
4.63 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
8.49 | 11000095 |
MESH:D006470 |
Hemorrhage |
|
Warfarin |
8.49 | 18429757 |
MESH:D006486 |
Hemosiderosis |
|
Iron |
4.53 | 16604332 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
4.85 | 14986274 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
7.72 | 19900420 19110552 |
MESH:D006505 |
Hepatitis |
|
cypermethrin |
7.72 | 16487989 |
MESH:D006525 |
Hepatitis, Viral, Human |
|
Iron |
4.78 | 16640825 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Iron |
4.28 | 17182432 |
MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
20.26 | 15265979 |
MESH:D006529 |
Hepatomegaly |
|
Iron |
20.26 | 16890145 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
20.26 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
20.26 | 18467677 16221962 19176532 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
20.26 | 15340226 16120746 12621046 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.52 | 16876885 |
MESH:D015658 |
HIV Infections |
|
Iron |
3.29 | 16597321 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
5.74 | 16135485 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
5.74 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.36 | 18606429 8697196 16959395 15340226 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
5.83 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
5.83 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
3.86 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
27.73 | 8137927 9751232 |
MESH:D006937 |
Hypercholesterolemia |
|
atorvastatin |
27.73 | 11583720 |
MESH:D006937 |
Hypercholesterolemia |
|
Cholesterol |
27.73 | 16933029 |
MESH:D006937 |
Hypercholesterolemia |
|
Cholesterol, Dietary |
27.73 | 10876104 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
27.73 | 21332399 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
27.73 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
3.91 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
7.28 | 20558911 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
7.28 | 11834736 18262572 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Phenytoin |
4.10 | 10459572 |
MESH:D006946 |
Hyperinsulinism |
|
Fructose |
4.33 | 14757778 18563319 19008412 18360027 15752949 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
3.86 | 17050553 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
12.01 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Fructose |
12.01 | 15752949 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
12.01 | 16873680 |
MESH:D006951 |
Hyperlipoproteinemias |
marker/mechanism |
|
| |
MESH:D006938 |
Hyperlipoproteinemia Type II |
marker/mechanism |
|
| 16030523 |
MESH:D006938 |
Hyperlipoproteinemia Type II |
|
atorvastatin |
4.62 | 16238680 |
MESH:D006952 |
Hyperlipoproteinemia Type III |
marker/mechanism |
|
| |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
3.78 | 12960047 14722030 |
MESH:D006973 |
Hypertension |
|
Arsenic |
27.96 | 16076760 11953799 9931084 |
MESH:D006973 |
Hypertension |
|
atorvastatin |
27.96 | 17042910 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
27.96 | 10903974 |
MESH:D006973 |
Hypertension |
|
Enalapril |
27.96 | 12717102 10903974 |
MESH:D006973 |
Hypertension |
|
Fructose |
27.96 | 14568997 16843071 14633139 19008412 14573337 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
27.96 | 8949925 12717712 |
MESH:D006973 |
Hypertension |
|
Quercetin |
27.96 | 18356687 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
27.96 | 18670907 18850075 |
MESH:D006973 |
Hypertension |
|
valsartan |
27.96 | 12692753 20102058 18390891 18344623 10903974 16475468 11427623 12850387 |
MESH:D006974 |
Hypertension, Malignant |
|
valsartan |
5.72 | 11560862 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.43 | 15338365 |
MESH:D006976 |
Hypertension, Pulmonary |
|
Warfarin |
4.31 | 12359135 |
MESH:D015228 |
Hypertriglyceridemia |
marker/mechanism |
|
| |
MESH:D015228 |
Hypertriglyceridemia |
|
Fructose |
4.49 | 19342510 19799862 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
3.95 | 18502941 12791704 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.71 | 17488730 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
4.87 | 16093927 |
MESH:D007006 |
Hypogonadism |
|
Iron |
3.90 | 16640825 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
9.07 | 16002989 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
9.07 | 16945680 16569931 |
MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
9.51 | 18020914 17991464 |
MESH:D007037 |
Hypothyroidism |
|
Iron |
9.51 | 16640825 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
4.65 | 16076520 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
3.99 | 17600658 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
3.72 | 15036965 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
2.84 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
8.52 | 16517039 7193160 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
8.52 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
8.52 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
atorvastatin |
21.68 | 16908763 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
21.68 | 20412841 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
21.68 | 18785209 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
21.68 | 17963957 9205823 17255318 17237260 12878042 |
MESH:D007249 |
Inflammation |
|
polyphenols |
21.68 | 16366677 |
MESH:D007249 |
Inflammation |
|
resveratrol |
21.68 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
21.68 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
21.68 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
14.72 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
14.72 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
14.72 | 16624496 |
MESH:D007299 |
Insect Bites and Stings |
|
cypermethrin |
5.29 | 15189238 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
9.74 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
Fructose |
9.74 | 14633139 19799862 18563319 17133782 19008412 14757778 19586609 18981581 19342510 14573337 18057795 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
9.74 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.12 | 17994277 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Iron |
9.52 | 17163184 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
9.52 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
7.92 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
7.92 | 15992940 17551590 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.30 | 17086741 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.76 | 15604871 |
MESH:D007642 |
Keratosis |
|
Arsenic |
4.32 | 16930632 12749816 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
26.46 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Acrolein |
26.46 | 12488133 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
26.46 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Enalapril |
26.46 | 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
26.46 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
26.46 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Streptozocin |
26.46 | 12093613 |
MESH:D007674 |
Kidney Diseases |
|
valsartan |
26.46 | 16893502 10903974 12164870 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.28 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
9.24 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
9.24 | 16762066 14681315 15003126 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
9.24 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.36 | 16316344 |
MESH:D007859 |
Learning Disorders |
|
Cholesterol |
7.95 | 17134702 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
7.95 | 17184923 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
8.38 | 10602166 |
MESH:D007938 |
Leukemia |
|
Quercetin |
8.38 | 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
8.38 | 17143497 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.17 | 17802794 17658394 18172266 17008537 18587576 17296974 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
3.57 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.10 | 19285840 16932348 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
1.94 | 17596541 19850784 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
10.10 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
10.10 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
10.10 | 17712046 16766008 9834237 15748426 16140955 17368321 19035177 12679006 19225113 17506722 17301526 17217047 17361223 16331271 16823087 16891316 17294898 19075265 16935935 19029980 19642359 16788101 17107899 17649720 17339181 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
9.54 | 11830472 10052129 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
9.54 | 15821434 |
MESH:D020961 |
Lewy Body Disease |
|
Iron |
4.77 | 16563566 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
2.81 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Amiodarone |
6.24 | 15342952 17567588 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
6.24 | 15342952 17567588 |
OMIM:611771 |
LIPOPROTEIN GLOMERULOPATHY |
marker/mechanism |
|
| |
MESH:D054068 |
Livedo Reticularis |
|
Warfarin |
6.03 | 18280355 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
16.36 | 21278145 11903743 17334410 16239168 11408273 16221502 17174718 16943688 17157831 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
16.36 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
16.36 | 18665156 20032147 18522880 19638242 18407596 |
MESH:D008103 |
Liver Cirrhosis |
|
Iron |
16.36 | 16640825 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
16.36 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
alpha-naphthyl isocyanate |
17.80 | 16015684 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
atorvastatin |
17.80 | 17347453 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
17.80 | 15996030 12389079 18279442 15818738 12586293 14620537 18156304 17761835 16248980 18006644 12741479 15925388 17944888 14716496 17557913 17708605 17565644 18472332 12445421 16015684 16192424 14512876 18339082 15370692 17721639 12666154 18166357 17823541 15123356 18277467 12667390 18251166 10355542 18376398 15057751 17714472 15362042 14748882 15730626 17698563 16027843 16638106 15893842 18420326 15673190 18472094 18395914 17900296 17525996 12649538 12546737 14724832 18481824 12445418 13678700 14716833 18412020 20821823 16116963 17922224 12632514 16097048 18205269 18263696 15338365 11481614 12958196 15931870 17640975 17869086 17766677 18395095 17631135 17481882 12632512 17976157 12898905 15959796 18418968 18054572 15650968 12609069 18317297 16033810 18210741 16011737 17805973 15052691 15876570 16136751 18429990 18187930 18705752 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Enalapril |
17.80 | 17347453 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
17.80 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
17.80 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
17.80 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
17.80 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
17.80 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
17.80 | 18397230 16248980 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
valsartan |
17.80 | 15504291 16872305 15619341 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
18.91 | 12969438 11587558 16611625 19460945 19014921 16610002 19784758 12587719 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
18.91 | 11134558 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
18.91 | 16246199 16964402 15830285 17285989 15720792 |
MESH:D008107 |
Liver Diseases |
|
cypermethrin |
18.91 | 15991261 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
18.91 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
18.91 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
Phenytoin |
18.91 | 14986274 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
18.91 | 16698588 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Iron |
4.35 | 16737972 17207112 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.51 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
7.45 | 17185352 16871587 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
7.45 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
38.95 | 2125692 15890375 18177683 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
38.95 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
38.95 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
38.95 | 20583210 18648771 18978307 19690152 19090486 20101389 19551842 19254457 19642983 19426721 19850985 15175105 21071580 19812893 15885732 18644402 19996281 19294768 20118626 18977376 21167192 18754104 20405173 20452335 21047994 9163691 20501860 16942905 20434301 21278145 20492335 20137499 19255062 19499222 2862719 12112319 2422723 19256749 10737359 12771043 19638242 19427195 19833225 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
38.95 | 15890375 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Iron |
38.95 | 16640825 20302851 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
38.95 | 19073162 8742319 19812893 15975961 21047994 19482888 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
38.95 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
38.95 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
38.95 | 19321006 19073162 20405173 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
38.95 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
38.95 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
38.95 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
17.51 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
17.51 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
17.51 | 17854601 19126423 19009564 18253720 9362446 18775883 16267830 18093689 17174075 18164116 17942915 18079962 19004024 18544905 3124819 16842330 19519916 18308698 2563599 18282651 21159647 19539802 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
17.51 | 18308698 1399818 2563599 6150874 17172636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
17.51 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
17.51 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
3.06 | 17391786 15350150 11989578 |
MESH:D008171 |
Lung Diseases |
|
Acrolein |
13.71 | 11504702 |
MESH:D008171 |
Lung Diseases |
|
Amiodarone |
13.71 | 12587719 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
13.71 | 19066396 8266340 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
13.71 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
3.80 | 18516814 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
7.08 | 21114838 |
MESH:D055370 |
Lung Injury |
|
Ozone |
7.08 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
marker/mechanism |
|
| 19180532 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
12.90 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
12.90 | 17306315 19168569 17976673 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
12.90 | 21163286 6695378 20970405 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Iron |
12.90 | 16640825 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
12.90 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
12.90 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
12.90 | 16712894 15276417 17077188 19931552 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
12.90 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
12.90 | 19555203 11884234 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.48 | 15166399 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
6.22 | 12854902 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
6.22 | 15700306 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
8.41 | 16675587 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
8.41 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
7.16 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
7.16 | 14749477 |
MESH:D008268 |
Macular Degeneration |
marker/mechanism |
|
| |
MESH:D008268 |
Macular Degeneration |
|
Iron |
3.57 | 16640825 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
4.83 | 16002989 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
7.78 | 15688416 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
7.78 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
7.36 | 8985016 11606380 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
7.36 | 15318939 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
7.36 | 19196723 14580682 16827153 11731420 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
3.86 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.47 | 17453147 |
MESH:D008545 |
Melanoma |
|
resveratrol |
5.90 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
5.90 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
5.90 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
5.90 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.51 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
14.70 | 19513568 |
MESH:D008546 |
Melanoma, Experimental |
|
Acrolein |
14.70 | 10803710 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
14.70 | 16388313 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.77 | 16940565 |
MESH:D008607 |
Mental Retardation |
|
Phenytoin |
3.40 | 9212184 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.48 | 15107826 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.77 | 17112576 |
MESH:D024821 |
Metabolic Syndrome X |
|
Fructose |
4.26 | 16815490 19165636 17098227 18497449 17261469 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.10 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.42 | 10496685 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
2.98 | 16267019 14749477 16490592 17935668 17049120 17164350 |
MESH:D009103 |
Multiple Sclerosis |
marker/mechanism |
|
| |
MESH:D020528 |
Multiple Sclerosis, Chronic Progressive |
|
Iron |
4.99 | 17086897 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.20 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
atorvastatin |
14.15 | 16239165 |
MESH:D009135 |
Muscular Diseases |
|
Bezafibrate |
14.15 | 16239165 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
14.15 | 16239165 |
MESH:D009181 |
Mycoses |
|
Amiodarone |
10.87 | 17974566 12754197 |
MESH:D009181 |
Mycoses |
|
Iron |
10.87 | 16640825 |
MESH:D015878 |
Mydriasis |
|
Tropicamide |
6.67 | 16308726 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
2.66 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
marker/mechanism |
|
| |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
7.57 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
7.57 | 19595682 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
7.57 | 17125593 16525036 16317513 17188708 17015251 16456233 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
17.39 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
Iron |
17.39 | 16604332 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
17.39 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
17.39 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Iron |
11.25 | 16604332 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
11.25 | 16411023 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
11.25 | 19207477 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.09 | 17322642 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
10.26 | 17484760 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenytoin |
10.26 | 17484760 |
MESH:D009224 |
Myotonia Congenita |
|
Phenytoin |
4.74 | 1896199 |
MESH:D009336 |
Necrosis |
|
Warfarin |
4.88 | 14723717 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
4.66 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
4.66 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.25 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Acrolein |
18.20 | 17329238 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
18.20 | 18854779 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
18.20 | 15313581 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
18.20 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
18.20 | 15185748 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
18.20 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
18.20 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
7.07 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
7.07 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.32 | 19196722 19200415 19189210 |
MESH:D009393 |
Nephritis |
|
Acrolein |
5.60 | 12653641 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.76 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
atorvastatin |
17.98 | 19348381 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
17.98 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Hypolipidemic Agents |
17.98 | 19603250 |
MESH:D009404 |
Nephrotic Syndrome |
|
Iron |
17.98 | 17178036 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
12.71 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
12.71 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
12.71 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
13.55 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
Phenytoin |
13.55 | 9118846 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
13.55 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
13.55 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
3.25 | 8761367 15176712 16115947 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
20.47 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acrolein |
20.47 | 11342003 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
20.47 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Iron |
20.47 | 17296847 16604332 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
20.47 | 17652729 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.22 | 8761367 12837982 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
14.22 | 17056641 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
14.22 | 17929310 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
14.22 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.43 | 20387270 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
3.71 | 8291058 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Cholesterol |
5.05 | 20557099 9802331 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
6.21 | 21332399 20518802 18674790 20132043 19632207 18457598 11836018 17217161 16723640 |
MESH:D009765 |
Obesity |
|
Fructose |
6.21 | 18585860 17707055 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
6.21 | 20558911 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.04 | 16517039 |
MESH:D010003 |
Osteoarthritis |
|
Iron |
3.53 | 16640825 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
9.85 | 17016548 |
MESH:D010018 |
Osteomalacia |
|
Phenytoin |
9.85 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
6.20 | 17882678 |
MESH:D010024 |
Osteoporosis |
|
Iron |
6.20 | 16648989 16640825 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
8.14 | 19495926 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
8.14 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
9.09 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
9.09 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
9.09 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
9.09 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
11.65 | 16870215 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
11.65 | 18093676 12161096 |
MESH:D010146 |
Pain |
|
Phenytoin |
11.65 | 15215642 |
MESH:D010146 |
Pain |
|
Tretinoin |
11.65 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
13.14 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
13.14 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
13.14 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
13.14 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
13.14 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.06 | 11578682 |
MESH:D010212 |
Papilloma |
|
Iron |
3.84 | 12065085 |
MESH:D020447 |
Parasomnias |
|
Iron |
5.33 | 17352947 |
MESH:D010300 |
Parkinson Disease |
|
Acrolein |
10.01 | 17690948 |
MESH:D010300 |
Parkinson Disease |
|
Cholesterol, Dietary |
10.01 | 19014385 |
MESH:D010300 |
Parkinson Disease |
|
Iron |
10.01 | 16640825 16563566 |
MESH:D010300 |
Parkinson Disease |
|
tolcapone |
10.01 | 11586115 18328768 8739811 10651109 16758261 19578428 7566641 11432539 9708959 11793426 19783845 9333106 9591521 20334432 9305320 17089403 9754991 11746615 1977408 8635184 20216409 |
MESH:D020734 |
Parkinsonian Disorders |
|
Tropicamide |
5.17 | 17594079 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.56 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
3.54 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
4.32 | 6392382 15371236 16905509 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.48 | 16369182 |
MESH:D010787 |
Photosensitivity Disorders |
|
Acrolein |
5.05 | 11550810 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
11.79 | 14722030 |
MESH:D010900 |
Pituitary Diseases |
|
Iron |
11.79 | 16604332 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
4.01 | 16977796 15687265 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.20 | 15087411 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
8.88 | 11605937 12224865 |
MESH:D011014 |
Pneumonia |
|
Ozone |
8.88 | 18929643 18007984 18381685 |
MESH:D011041 |
Poisoning |
|
Iron |
3.68 | 16604332 |
MESH:D017689 |
Polydactyly |
|
Phenytoin |
4.47 | 9212184 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Iron |
8.90 | 16640825 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
8.90 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
17.18 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
17.18 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
17.18 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
17.18 | 19056647 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.39 | 21297632 |
MESH:D011225 |
Pre-Eclampsia |
|
Iron |
3.89 | 16640825 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
12.45 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
12.45 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
12.45 | 11222880 11118676 11399792 11896295 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
1.97 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
1.97 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
1.97 | 15846301 15046698 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
1.97 | 14715546 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
1.97 | 15767336 17804756 16731767 17636462 17718901 17675339 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.97 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.97 | 15067354 |
MESH:D020151 |
Protein C Deficiency |
|
Warfarin |
5.67 | 18376272 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
12.02 | 21343184 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
12.02 | 16636307 |
MESH:D011507 |
Proteinuria |
|
valsartan |
12.02 | 17664856 18344623 12164870 |
MESH:D011528 |
Protozoan Infections |
|
Iron |
5.33 | 16640825 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.65 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
10.29 | 12752131 |
MESH:D019310 |
Pseudolymphoma |
|
Phenytoin |
10.29 | 1419762 8603615 12752131 |
MESH:D011565 |
Psoriasis |
marker/mechanism |
|
| 16433808 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
1.95 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.12 | 16723453 |
MESH:D011655 |
Pulmonary Embolism |
|
Warfarin |
5.67 | 19300499 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
10.79 | 11597910 12490602 12832656 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
10.79 | 16636934 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Enalapril |
10.79 | 17265423 |
MESH:D011658 |
Pulmonary Fibrosis |
|
valsartan |
10.79 | 17241526 |
MESH:D051437 |
Renal Insufficiency |
|
Acrolein |
9.10 | 12732208 |
MESH:D051437 |
Renal Insufficiency |
|
Enalapril |
9.10 | 15728788 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
4.90 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
5.31 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
5.31 | 17520802 16317513 16314181 17058453 15827377 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Acetylcholine |
6.98 | 9413022 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
6.98 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.20 | 18990726 |
MESH:D012148 |
Restless Legs Syndrome |
|
Iron |
4.02 | 16930377 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.48 | 16116481 16283617 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
4.86 | 16862918 |
MESH:D012559 |
Schizophrenia |
marker/mechanism |
|
| 18583979 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.20 | 16636934 |
MESH:D012618 |
Sea-Blue Histiocyte Syndrome |
marker/mechanism |
|
| |
MESH:D012640 |
Seizures |
|
Phenobarbital |
4.80 | 4039156 3137016 11442880 16876388 |
MESH:D012640 |
Seizures |
|
Phenytoin |
4.80 | 19919933 15946322 16876388 11044598 3691417 9844417 10029267 3137016 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.15 | 6407741 |
OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
4.41 | 18724381 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.03 | 7327846 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Warfarin |
5.21 | 12269725 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.54 | 15952646 19834688 17548696 18709164 17050553 16702368 17453740 6392382 17938729 16353154 16759981 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
21.59 | 19538983 17050553 15504454 16251483 17029826 17976673 |
MESH:D012878 |
Skin Neoplasms |
|
Iron |
21.59 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
21.59 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
21.59 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
21.59 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
21.59 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
21.59 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
16.19 | 16709447 16002989 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
16.19 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
16.19 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
4.84 | 16517039 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.37 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.26 | 12854658 |
MESH:D013163 |
Splenomegaly |
marker/mechanism |
|
| |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Phenytoin |
4.50 | 20235791 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.92 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
2.92 | 12958204 17575124 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.92 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
2.74 | 18087811 |
MESH:D020521 |
Stroke |
|
Acrolein |
7.71 | 16269634 |
MESH:D020521 |
Stroke |
|
Warfarin |
7.71 | 19300499 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
3.89 | 16321402 |
MESH:D013398 |
Sudden Infant Death |
|
Iron |
4.78 | 16640825 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.39 | 12837982 |
MESH:D013610 |
Tachycardia |
|
Amiodarone |
3.65 | 11238279 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
3.55 | 19225199 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
4.57 | 17997062 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.58 | 15821434 |
MESH:D013923 |
Thromboembolism |
|
Acenocoumarol |
11.87 | 18698879 |
MESH:D013923 |
Thromboembolism |
|
Warfarin |
11.87 | 16960144 18698879 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
8.95 | 11994571 |
MESH:D019851 |
Thrombophilia |
|
Warfarin |
8.95 | 17493413 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
7.51 | 15669648 |
MESH:D013927 |
Thrombosis |
|
Warfarin |
7.51 | 11518727 17245631 11307788 15720958 17672075 19300499 |
MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
9.78 | 19731979 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
9.78 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
8.93 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
8.93 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
8.93 | 16026305 17045167 |
MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
4.20 | 18020914 19584973 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
7.95 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
7.95 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
3.52 | 11989578 17467628 |
MESH:D014202 |
Tremor |
|
Tropicamide |
5.52 | 17594079 19467297 |
MESH:D014376 |
Tuberculosis |
|
Iron |
6.67 | 16597321 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
6.67 | 16040207 |
MESH:D018088 |
Tuberculosis, Multidrug-Resistant |
|
tolcapone |
5.26 | 19578428 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
15.74 | 19429237 17976673 18640142 15987713 17306315 19322015 11144890 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
15.74 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
15.74 | 16712894 16452187 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
15.74 | 16720314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
15.74 | 16712894 17306315 11723127 16452187 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
15.74 | 17572228 8653321 16712894 |
MESH:D014570 |
Urologic Diseases |
|
cypermethrin |
5.18 | 16487989 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.36 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
17.82 | 16175088 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
17.82 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
17.82 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
17.82 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
4.48 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
12.39 | 16690809 15809267 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
12.39 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
12.39 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
3.93 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.30 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
3.78 | 16513791 16002989 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
9.62 | 17056641 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
9.62 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.91 | 12125929 |
MESH:D014657 |
Vasculitis |
|
Warfarin |
5.21 | 20337814 |
MESH:D054556 |
Venous Thromboembolism |
|
Warfarin |
5.68 | 18776969 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
8.73 | 14671159 15869587 |
MESH:D020246 |
Venous Thrombosis |
|
Warfarin |
8.73 | 14723717 15733061 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
3.65 | 17488730 |
MESH:D020257 |
Ventricular Remodeling |
|
valsartan |
5.03 | 19027736 |
MESH:D014820 |
Vitiligo |
|
tolcapone |
8.97 | 10573327 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
8.97 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.56 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.16 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.39 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.76 | 17120751 |